IMAGE: TERESA MEIER, M.D., ASSISTANT PROFESSOR OF RADIATION ONCOLOGY AT THE UC COLLEGE OF MEDICINE AND A UC HEALTH RADIATION ONCOLOGIST, IS STUDYING THE EFFECTS OF PROTON RADIATION THERAPY ON PATIENTS… view more CREDIT: COLLEEN KELLEY...
Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cancer...
Mary Terry for Biospace writes: T3D Therapeutics, based in Research Triangle Park, NC, received a $9 million grant over four years from the National Institute on Aging (NIA), part of theNational Institutes of Health (NIH). The funds will be used to partially support a...
Strata Oncology, Inc., a precision oncology company, today announced that data from its Strata Trial, a nationwide observational NGS screening protocol providing no-cost tumor sequencing and clinical trial matching for 100,000 advanced cancer patients, will be...
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company has completed its Type C CMC meeting and has reached agreement with the U.S. Food and...
RVT-1601 previously demonstrated a statistically significant and clinically meaningful reduction in IPF-related cough in a Phase 2a study Respivant also launches new website – IPFCough.com – as educational resource for patients and to increase awareness of...
Email
Text